- FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.Fierce Biotech · 6d ago↗ source
- Webinar: From Clinical to Commercial: Talent Strategies for Biopharma GrowthThis webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate…BioSpace · 6d ago↗ source
- Vertex was sole bidder in high-premium Crinetics acquisitionAnalysts expect new details on the lead-up to the deal “are likely to reignite” investor scrutiny that Vertex overpaid in what’s poised to be its largest-ever transaction.